Mutant KRAS in ctDNA in patients with localized pancreatic cancer was shown to be a biomarker for metastatic progression and ...

Ovarian cancer is particularly dangerous due to the high risk of metastasis. Researchers have developed a molecule capable, under light control, of specifically targeting peritoneal metastases and ...

Bone metastases can occur in any part of the skeleton ... grow in the fluid surrounding the brain and the spinal cord. The peritoneal cavity, which contains the abdominal organs, is a less ...

Targeted chemotherapy in the abdomen using a technique called PIPAC combined with systemic standard-of-care chemotherapy is shown to be safe, with promising activity for patients with colorectal and a ...

More than 70% of people with this type of cancer already have metastasis when they’re diagnosed ... in the space around the ovary, called the peritoneal cavity. Stage II ovarian cancer.

Instead, they adhere to tissues in the peritoneal cavity and seed multiple metastatic sites. To anchor themselves in these different tissues, the cells release proteases to degrade the extracellular ...

PFS benefit was seen across all pre-specified subgroups (eg, KRAS or NRAS mutations as well as baseline liver, lung or peritoneal metastases). Findings also showed at 47 months, nivolumab plus ...

focuses on peritoneal adipose-derived stem cells (ADSCs), a key component of the tumor microenvironment, as significant contributors to OC metastasis. The researchers isolated adipocytes and ADSCs ...

Ovarian cancer is particularly dangerous due to the high risk of metastasis. Researchers have developed a molecule capable, under light control, of specifically targeting peritoneal metastases and ...

When surgery is not an option and peritoneal metastases are left untreated, these patients survive only a few months and few make it past one year with standard treatment. “Up until recently ...